西格列汀联合二甲双胍治疗2型糖尿病1例
摘要
患者资料
患者，男．43岁，出租车司机。以“口干多饮、多尿、体重减轻（约5kg）3年”入院。在我院经监测血糖及OGTT确诊为2型糖尿病，给予饮食运动控制，
出处
《药品评价》
CAS
2011年第21期65-67,共3页
Drug Evaluation
参考文献11
-
1Orskov C, Holst JJ, Knuhtsen S, et al. Glucagon-like peptides GLP-1 and GLP-2, predicted of the glucagons gene, are secreted separately from pig small intestine but not pancreas[J]. Endocrinology, 1986, 119: 1467-1475.
-
2Holst JJ. Therapy of type 2 diabetes mellitus based on the actions of glucagons-like eptide-1[J]1J. Diabetes Metab Res Rev, 2002,18: 430-441.
-
3Deacon CE Nanck MA, Meier I, et al. Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide[J]. J Clin Endocrinol Metab, 2000, 85: 3575-3581.
-
4Vilsboll T, Agerso H, Kvarup T, et al. Similar elimination rates of glucagon-like peptide 1 in obese type 2 diabetic patients and healthy subjects[J]. J Clin Endocfinol Metal), 2(X)3, 88: 220-224.
-
5Vilsbell T, Hoist JJ. Incretins, insulin secretion and type 2 diabetes mellitus[J]. Diabetologia, 2004, 47: 357-366.
-
6Nauck MA. Glucagon like peptide t (GLP 1) in the treatment of diabetes[J]. Horm Metab Res, 2004, 36: 852-858.
-
7Dungan K, Buse JB. Glucagon like peptide l-based therapies for type 2 diabetes: a focus on exenatide[J]. Clin Diabetes, 2005, 23:56-62.
-
8Mu J, Petrov A, Eiermann GJ, et al. Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes[J]. Eur I Pharmacol, 2009, 623( 1-3): 148-154.
-
9Duttaroy A, Voelker F, Merriam K, et al. The DPP-4 inhibitor vildagliptin increases pancreatic beta cell neogenesis and decreases apoptosis[J]. Diabetes, 2005, 54(Suppl 1): A141.
-
10MacDonald PE, EI-Kholy W,, Riedel MJ, et al. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion[J]. Diabetes, 2002, 51(Suppl 3): 8434-442.
-
1徐勍.对比观察DPP-4抑制剂单药及联合用药治疗糖尿病的临床效果[J].家庭心理医生,2015,11(3):286-287.
-
2黄婉嫦,林继新,黄国秋.DPP-4抑制剂联合二甲双胍在2型糖尿病治疗中的应用研究[J].现代诊断与治疗,2016,27(19):3533-3535. 被引量：1
-
3洪文婕.二甲双胍联合磷酸西格列汀片治疗糖尿病的疗效及安全性[J].实用临床医学（江西）,2017,18(2):1-2. 被引量：10
-
4张彦忠,叶海燕,陈大双,周径,吴晓丽.磷酸西格列汀联合二甲双胍治疗新诊断2型糖尿病的疗效观察[J].实用糖尿病杂志,2015,11(2):42-43. 被引量：8
-
5丁晓慧.磷酸西格列汀联合二甲双胍治疗初发2型糖尿病的临床观察[J].中国当代医药,2016,23(28):72-74. 被引量：9
-
6裴晓艳,毕娅欣,金国玺,于磊.DPP-4抑制剂联合胰岛素治疗血糖控制不佳的2型糖尿病疗效研究[J].齐齐哈尔医学院学报,2015,36(35):5307-5309. 被引量：2
-
7滕常青,李鹏飞.甲钴胺治疗糖尿病周围神经病变60例临床观察[J].医学信息（下旬刊）,2011,24(2):146-147.
-
8周迪军,孙文利,丁蓉,双振宇,谢明,梁艳芳.西格列汀联合二甲双胍治疗2型糖尿病的临床效果[J].中国医药导报,2014,11(15):84-86. 被引量：52
-
9钟立胜.维格列汀联合胰岛素治疗2型糖尿病1例[J].药品评价,2013(21):43-44.
-
10易志,寇艳.对出租车司机心电图ST-T改变的分析[J].华西医学,2008,23(5):1132-1133.
